BlackRock’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109M Buy
9,434,496
+2,766,674
+41% +$32M ﹤0.01% 1965
2025
Q1
$58.2M Sell
6,667,822
-102,429
-2% -$894K ﹤0.01% 2275
2024
Q4
$97.2M Sell
6,770,251
-45,119
-0.7% -$648K ﹤0.01% 2082
2024
Q3
$154M Buy
6,815,370
+422,720
+7% +$9.55M ﹤0.01% 1799
2024
Q2
$124M Buy
6,392,650
+385,007
+6% +$7.49M ﹤0.01% 1889
2024
Q1
$225M Buy
6,007,643
+302,251
+5% +$11.3M 0.01% 1562
2023
Q4
$319M Buy
5,705,392
+219,098
+4% +$12.3M 0.01% 1323
2023
Q3
$226M Buy
5,486,294
+83,338
+2% +$3.44M 0.01% 1443
2023
Q2
$302M Buy
5,402,956
+163,849
+3% +$9.15M 0.01% 1279
2023
Q1
$292M Sell
5,239,107
-80,517
-2% -$4.49M 0.01% 1277
2022
Q4
$194M Buy
5,319,624
+227,061
+4% +$8.27M 0.01% 1546
2022
Q3
$145M Sell
5,092,563
-1,729,685
-25% -$49.3M ﹤0.01% 1702
2022
Q2
$309M Sell
6,822,248
-2,334,744
-25% -$106M 0.01% 1202
2022
Q1
$697M Buy
9,156,992
+1,138,358
+14% +$86.6M 0.02% 750
2021
Q4
$1.19B Sell
8,018,634
-336,042
-4% -$50.1M 0.03% 536
2021
Q3
$1.22B Buy
8,354,676
+805,501
+11% +$117M 0.03% 498
2021
Q2
$1.48B Buy
7,549,175
+2,242,036
+42% +$439M 0.04% 447
2021
Q1
$961M Buy
5,307,139
+144,119
+3% +$26.1M 0.03% 596
2020
Q4
$731M Buy
5,163,020
+1,874,510
+57% +$265M 0.02% 663
2020
Q3
$410M Buy
3,288,510
+1,584,772
+93% +$198M 0.02% 865
2020
Q2
$152M Buy
1,703,738
+1,238,609
+266% +$111M 0.01% 1544
2020
Q1
$29M Buy
465,129
+107
+0% +$6.67K ﹤0.01% 2375
2019
Q4
$35.5M Sell
465,022
-448,320
-49% -$34.2M ﹤0.01% 2538
2019
Q3
$46M Buy
+913,342
New +$46M ﹤0.01% 2324